AlphaFold predicted structure
SOX18 · P35713

Mean pLDDT
62.0/ 100
Low
384 residues
Confidence breakdown
- Very high(≥ 90)19%
- Confident(70–90)9%
- Low(50–70)33%
- Very low(< 50)39%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
SRY-box transcription factor 18
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Fetal anomalies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPigmentary skin disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPrimary lymphoedema
BOTH monoallelic and biallelic, autosomal or pseudoautosomalVascular skin disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalHereditary haemorrhagic telangiectasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalHypotrichosis - lymphedema - telangiectasia
neurodegenerative disease
Glomerulonephritis - sparse hair - telangiectasis
Varicose veins
pulmonary embolism
vein disorder
hereditary disease
venous thromboembolism
lymphatic system disorder
septic shock
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transcription factor SOX-18
Transcriptional activator that binds to the consensus sequence 5'-AACAAAG-3' in the promoter of target genes and plays an essential role in embryonic cardiovascular development and lymphangiogenesis. Activates transcription of PROX1 and other genes coding for lymphatic endothelial markers. Plays an essential role in triggering the differentiation of lymph vessels, but is not required for the maintenance of differentiated lymphatic endothelial cells. Plays an important role in postnatal angiogenesis, where it is functionally redundant with SOX17. Interaction with MEF2C enhances transcriptional activation. Besides, required for normal hair development
SOX18 · P35713

Mean pLDDT
62.0/ 100
Low
384 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0